Xcout IntelSign inSubscribe

Nuclera competitors & alternatives

BiotechnologySingapore

The 12 closest competitors and alternatives to Nuclera among biotechnology companies — ranked by similarity to what Nuclera actually does, not by market-cap band.

12Competitors listed

Subscribe to see Nuclera’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Nuclera

Nuclera provides products and services for multiplex protein screening and expression, including the eProtein Discovery system and related reagents, software, and services. The company serves researchers and scientists in drug discovery and biotechnology by enabling them to perform in-house protein design, screening, characterization, and small-scale expression.

Nuclera at a glance

Nuclera is a biotechnology company headquartered in Singapore. Xcout tracks 14 named people at Nuclera, including Seth Benson (Chief Financial Officer).

Nuclera leadership

  • Seth BensonChief Financial Officer
  • Michael ChenFounder and CEO
  • Gordon McInroyFounder and COO
  • Charu MainiSVP of People
  • Tobias OstSVP of Product Development
  • Colin BarnesVP of Intellectual Property

8 more named people on record for Nuclera, with roles, board committees and tenure — see the full roster →

Top 12 Nuclera competitors

Ranked by semantic similarity — how close each company is to Nuclera by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

Codexis, Inc.CDXS · BiotechRedwood City, United States
63% matchPublic

Biotech

Codexis, Inc. is a biotechnology firm dedicated to the discovery, development, and commercialization of enzymes and other protein-based solutions. Its diverse portfolio encompasses advanced biocatalyst products and related services, specialized chemical intermediates vital for subsequent processing steps, and proprietary biocatalyst panels and kits that empower clients to conduct effective chemistry screening. The company also extends its expertise through biocatalyst screening and sophisticated protein engineering services. Central to its operations is the proprietary CodeEvolver protein engineering technology platform. This innovative platform is instrumental in crafting and delivering high-performance biocatalysts capable of driving chemical transformations, thereby significantly enhancing the efficiency and productivity of manufacturing processes. Beyond industrial applications, the CodeEvolver platform is also leveraged for identifying novel biotherapeutic drug candidates for targeted human diseases, as well as for developing enzymes essential for molecular biology research and in vitro diagnostic applications. Primarily serving pharmaceutical manufacturers, Codexis distributes its products through its dedicated direct sales and business development teams across the United States and Europe. Established in 2002, the company maintains its headquarters in Redwood City, California.

Market cap$157M
Employees188
Codexis, Inc. competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Nuclera and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Nucleraand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →